Inhibition of CD40L with Frexalimab in Multiple Sclerosis. Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, et al. N Engl J Med 2024;390:589-600.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, et al. Inhibition of CD40L with Frexalimab in Multiple Sclerosis. N Engl J Med 2024;390:589-600.
PMID: 38354138